These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34325549)
1. Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients. Wang B; Xu P; Shu Q; Yan S; Xu H Clin Appl Thromb Hemost; 2021; 27():10760296211031291. PubMed ID: 34325549 [TBL] [Abstract][Full Text] [Related]
2. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women. Jusić A; Balić D; Avdić A; Pođanin M; Balić A Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881 [TBL] [Abstract][Full Text] [Related]
3. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121 [TBL] [Abstract][Full Text] [Related]
4. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion]. Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129 [TBL] [Abstract][Full Text] [Related]
5. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome? Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737 [TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis. Lee YH; Song GG Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532 [TBL] [Abstract][Full Text] [Related]
7. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease. Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage. Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss. Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167 [No Abstract] [Full Text] [Related]
10. Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis. Milenkovic J; Milojkovic M; Mitic D; Stoimenov TJ; Smelcerovic Z; Stojanovic D; Vujic S; Bojanic N J Assist Reprod Genet; 2020 Jun; 37(6):1449-1458. PubMed ID: 32399796 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence. Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493 [TBL] [Abstract][Full Text] [Related]
12. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review. Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171 [No Abstract] [Full Text] [Related]
14. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population. D'Amico M; Pasta F; Pasta L Gene; 2015 Aug; 568(1):85-8. PubMed ID: 25987440 [TBL] [Abstract][Full Text] [Related]
16. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome. Radaković B; Goldstajn MS Coll Antropol; 2007 Sep; 31(3):919-21. PubMed ID: 18041407 [TBL] [Abstract][Full Text] [Related]
17. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536 [TBL] [Abstract][Full Text] [Related]
18. Cilioretinal artery: Vasculogenesis might be promoted by plasminogen activator inhibitor-1 5G allele. Yilmaz S; Ardagil A; Akalin I; Altinel MG; Dag Y; Kurum E; Koyun E; Ari Yaylali S; Bayramlar H Ophthalmic Genet; 2017; 38(5):428-433. PubMed ID: 28145780 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study. Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome. Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]